Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Clinician's RoundtableMacitentan in Pediatric PAH: Results from the TOMORROW Trial
Early Recognition and Diagnostic Confidence in NTM Lung Disease
Clinician's RoundtableEarly Recognition and Diagnostic Confidence in NTM Lung Disease
Brian P. McDonough, MD, FAAFP
Doreen Addrizzo-Harris, MD
Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Clinician's RoundtableEmerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Alexandria May, PharmD, BCPS
David E. Griffith, MD
Managing Severe Asthma: 2026 GINA Strategy Report Recommendations
Clinician's RoundtableManaging Severe Asthma: 2026 GINA Strategy Report Recommendations
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Berstein, MD
Optimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableOptimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Alexandria May, PharmD, BCPS
Michael Czarnecki, MD
How to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableHow to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Brian P. McDonough, MD, FAAFP
Brooks Kuhn, MD, MAS
- advertisement
- 3 questions
- advertisement
Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Medical Industry FeatureTargeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Evaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Medical Industry FeatureEvaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Immune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
Medical Industry FeatureImmune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
- Asthma CSI: Behind the Cytokine Curtain, Part 1: Asthma HQMedical Industry FeatureAsthma CSI: Behind the Cytokine Curtain, Part 1: Asthma HQ
- 07/31/2026
- 07/31/2026
- 07/31/2026
- 07/28/2026
- 07/27/2026
- 07/27/2026